Neurocrine Biosciences shares owned by Smith Group Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Smith Group Asset Management
from 13F filings
Historical chart of Smith Group Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Smith Group Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Smith Group Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $317k | 2.3k | 140.38 |
| 2024-03-31 | $6.6M | 48k | 137.92 |
| 2023-12-31 | $9.0M | 69k | 131.76 |
More positions owned by Smith Group Asset Management
View all positions for Smith Group Asset Management